The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease.

NCT04605627 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-10-28

No results posted yet for this study

Summary

Define a signature of gut microbiota composition and related metabolites in patients with ST-elevation myocardial infarction, non ST-elevation myocardial infarction and chronic coronary disease (CAD).

Conditions

Sponsors & Collaborators

  • The Research Council of Norway

    collaborator OTHER
  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Marius Trøseid, Md Ass.prof · Oslo University Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-08
Primary Completion
2021-12-31
Completion
2023-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04605627 on ClinicalTrials.gov